The scientist’s investigation covers issues in Bloom syndrome, Genetics, Genome instability, DNA repair and Cancer. The various areas that Nathan A. Ellis examines in his Bloom syndrome study include Bloom syndrome protein and Cell biology. Gene, Candidate gene, Gene mapping and Gene duplication are subfields of Genetics in which his conducts study.
His DNA repair research includes themes of Molecular biology and Homologous recombination. His studies deal with areas such as Microsatellite instability, Family history and Histopathology as well as Cancer. His Breast cancer research is multidisciplinary, relying on both Incidence and Obstetrics.
Nathan A. Ellis mainly investigates Genetics, Bloom syndrome, Molecular biology, Gene and Internal medicine. He combines subjects such as Somatic cell, Founder effect, Transfection, Compound heterozygosity and Genome instability with his study of Bloom syndrome. Nathan A. Ellis works mostly in the field of Genome instability, limiting it down to topics relating to Promyelocytic leukemia protein and, in certain cases, Topoisomerase and Bloom syndrome protein, as a part of the same area of interest.
His Molecular biology research is multidisciplinary, incorporating perspectives in DNA damage, Homologous recombination, Sister chromatid exchange, DNA and DNA repair. Nathan A. Ellis interconnects Antibody and Sgs1 in the investigation of issues within Gene. He usually deals with Internal medicine and limits it to topics linked to Oncology and Breast cancer, Genetic counseling, Lynch syndrome, Lymphoma and Immunology.
His primary scientific interests are in Genetics, Internal medicine, Oncology, Ashkenazi jews and Bloom syndrome. His Genetics research focuses on Haplotype, Locus, Allele and Allele frequency. His research investigates the connection with Internal medicine and areas like Gynecology which intersect with concerns in Lynch syndrome, Genetic counseling, Penetrance, Genetic testing and MSH6.
His research in Ashkenazi jews intersects with topics in Breast cancer and Risk factor. His Bloom syndrome research incorporates elements of DNA, Molecular biology, Compound heterozygosity and Phosphorylated Histone H2AX. The Compound heterozygosity study which covers Missense mutation that intersects with Founder effect.
Nathan A. Ellis mostly deals with Bloom syndrome, Genetics, Mutation, Gene and Compound heterozygosity. His research integrates issues of Molecular biology, Genome instability, DNA and Phosphorylated Histone H2AX in his study of Bloom syndrome. His study in Genetics concentrates on Candidate gene, Haplotype, Single-nucleotide polymorphism, Locus and Genome-wide association study.
Nathan A. Ellis has researched Mutation in several fields, including Odds ratio, Incidence, Genotype, Breast cancer and Prostate cancer. His Gene study is mostly concerned with Founder effect and Missense mutation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Bloom's syndrome gene product is homologous to RecQ helicases
Nathan A. Ellis;Joanna Groden;Tian Zhang Ye;Joel Straughen.
Cell (1995)
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D. Kauff;Jaya M. Satagopan;Mark E. Robson;Lauren Scheuer.
The New England Journal of Medicine (2002)
Ku DNA end-binding protein modulates homologous repair of double-strand breaks in mammalian cells
Andrew J. Pierce;Peng Hu;Mingguang Han;Nathan Ellis.
Genes & Development (2001)
Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers
Lauren Scheuer;Noah Kauff;Mark Robson;Bridget Kelly.
Journal of Clinical Oncology (2002)
Prediction of Germline Mutations and Cancer Risk in the Lynch Syndrome
Sining Chen;Wenyi Wang;Shing Lee;Khedoudja Nafa.
JAMA (2006)
Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33
Bert Gold;Tomas Kirchhoff;Stefan Stefanov;James Lautenberger.
Proceedings of the National Academy of Sciences of the United States of America (2008)
Genetic evidence that ZFY is not the testis-determining factor
M. S. Palmer;A. H. Sinclair;P. Berta;Nathan Ellis.
Nature (1989)
Regulation and Localization of the Bloom Syndrome Protein in Response to DNA Damage
Oliver Bischof;Sahn Ho Kim;John Irving;Sergey Beresten.
Journal of Cell Biology (2001)
A role for PML and the nuclear body in genomic stability.
Sue Zhong;Peng Hu;Tian-Zhang Ye;Rodica Stan.
Oncogene (1999)
DNA helicases, genomic instability, and human genetic disease.
Anja J. van Brabant;Rodica Stan;Nathan A. Ellis.
Annual Review of Genomics and Human Genetics (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Memorial Sloan Kettering Cancer Center
Cornell University
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of North Carolina at Chapel Hill
Memorial Sloan Kettering Cancer Center
Abingworth
Memorial Sloan Kettering Cancer Center
Gifu University
City Of Hope National Medical Center
Purdue University West Lafayette
Abdullah Gül University
Zhejiang University
Bielefeld University
University of Tokyo
University of Strathclyde
University of Greifswald
REGENXBIO Inc.
University College Dublin
University of Salzburg
Brown University
KU Leuven
Concordia University
Northwestern University
University of Cincinnati Medical Center
University of Oxford